Unknown

Dataset Information

0

Whole-exome sequencing in clear cell sarcoma of soft tissue uncovers novel prognostic categorization and drug targets.

ABSTRACT:

SUBMITTER: Li J 

PROVIDER: S-EPMC8684775 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown New therapeutic targets in soft tissue sarcoma.
| S-EPMC3353406 | biostudies-other
Unknown Molecular targets and novel therapeutic avenues in soft-tissue sarcoma.
| S-EPMC7050044 | biostudies-literature
Unknown Integrated molecular characterization of adult soft tissue sarcoma for therapeutic targets.
| S-EPMC6311917 | biostudies-literature
Unknown Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention.
| S-EPMC8303572 | biostudies-literature
Unknown Constitutive activation of neuregulin/ERBB3 signaling pathway in clear cell sarcoma of soft tissue.
| S-EPMC1601931 | biostudies-literature
Unknown Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy.
| S-EPMC2911503 | biostudies-literature
Unknown Integrated Analysis of Nine Prognostic RNA-Binding Proteins in Soft Tissue Sarcoma.
| S-EPMC8138553 | biostudies-literature
Unknown Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma.
| S-EPMC4938996 | biostudies-literature
Unknown Immunotherapy in soft-tissue sarcoma.
| S-EPMC7050043 | biostudies-literature
Unknown Immunological and prognostic significance of novel ferroptosis-related genes in soft tissue sarcoma.
| S-EPMC8726495 | biostudies-literature